[HTML][HTML] Algae as nutritional and functional food sources: revisiting our understanding

ML Wells, P Potin, JS Craigie, JA Raven… - Journal of applied …, 2017 - Springer
Global demand for macroalgal and microalgal foods is growing, and algae are increasingly
being consumed for functional benefits beyond the traditional considerations of nutrition and …

[HTML][HTML] Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

AM Cantin, D Hartl, MW Konstan, JF Chmiel - Journal of Cystic Fibrosis, 2015 - Elsevier
Lung disease is the major cause of morbidity and mortality in patients with cystic fibrosis
(CF). Although CF lung disease is primarily an infectious disorder, the associated …

Resolvins and protectins: mediating solutions to inflammation

P Kohli, BD Levy - British journal of pharmacology, 2009 - Wiley Online Library
Resolution of inflammation has historically been viewed as a passive process, occurring as
a result of the withdrawal of pro‐inflammatory signals, including lipid mediators such as …

[HTML][HTML] Macrophage metabolic reprogramming during chronic lung disease

PP Ogger, AJ Byrne - Mucosal immunology, 2021 - Elsevier
Airway macrophages (AMs) play key roles in the maintenance of lung immune tolerance.
Tissue tailored, highly specialised and strategically positioned, AMs are critical sentinels of …

[HTML][HTML] Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy

L Li, S Somerset - Digestive and liver disease, 2014 - Elsevier
Cystic fibrosis can affect food digestion and nutrient absorption. The underlying mutation of
the cystic fibrosis trans-membrane regulator gene depletes functional cystic fibrosis trans …

Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients

J Yang, JP Eiserich, CE Cross, BM Morrissey… - Free Radical Biology …, 2012 - Elsevier
Retained respiratory tract (RT) secretions, infection, and exuberant inflammatory responses
are core abnormalities in cystic fibrosis (CF) lung disease. Factors contributing to the …

[HTML][HTML] Gastrointestinal manifestations of cystic fibrosis

S Sabharwal - Gastroenterology & hepatology, 2016 - ncbi.nlm.nih.gov
Cystic fibrosis has historically been considered a pulmonary disease, but with the increasing
life expectancy of these patients, gastrointestinal manifestations are becoming more …

Omega‐3 fatty acids for cystic fibrosis

C Oliver, H Watson - Cochrane Database of Systematic …, 2013 - cochranelibrary.com
Background Studies suggest that a diet rich in omega‐3 essential fatty acids may have
beneficial anti‐inflammatory effects for chronic conditions such as cystic fibrosis. Objectives …

Update on fat-soluble vitamins in cystic fibrosis

A Maqbool, VA Stallings - Current opinion in pulmonary medicine, 2008 - journals.lww.com
A paradigm shift has occurred in defining fat-soluble vitamin status by utilizing different
biomarkers and associations with health outcomes. Identification of additional biomarkers …

Antibiotic and anti-inflammatory therapies for cystic fibrosis

JF Chmiel, MW Konstan… - Cold Spring …, 2013 - perspectivesinmedicine.cshlp.org
Cystic fibrosis (CF) lung disease is characterized by chronic bacterial infection and an
unremitting inflammatory response, which are responsible for most of CF morbidity and …